Roger LiPatrick J. HensleyShilpa GuptaHikmat Al-AhmadieMarko BabjukPeter C. BlackMaurizio BrausiKelly K. BreeFERNANDEZ ARANCIBIA, MARIOMARIOFERNANDEZ ARANCIBIACharles C. GuoAmir HorowitzDonald L. LammSeth P. LernerYair LotanParamananthan MariappanDavid McConkeyLaura S. MertensCarmen MirJeffrey S. RossMichael O’DonnellJoan PalouKamal PoharGary SteinbergMark SolowayPhilippe E. SpiessRobert S. SvatekWei Shen TanRikiya TaokaRoger BuckleyAshish M. Kamat2024-10-222024-10-222024Li, R., Hensley, P. J., Gupta, S., Al-Ahmadie, H., Babjuk, M., Black, P. C., Brausi, M., Bree, K. K., Fernández, M. I., Guo, C. C., Horowitz, A., Lamm, D. L., Lerner, S. P., Lotan, Y., Mariappan, P., McConkey, D., Mertens, L. S., Mir, C., Ross, J. S., … Kamat, A. M. (2024). Bladder-sparing therapy for bacillus calmette-guérin–unresponsive non–muscle-invasive bladder cancer: International bladder cancer group recommendations for optimal sequencing and patient selection. European Urology, S0302283824025168. https://doi.org/10.1016/j.eururo.2024.08.001https://investigadores.udd.cl/handle/123456789/1034310.1016/j.eururo.2024.08.0012-s2.0-85202463250journal-article